Multi-Target Neuroprotection Lead Identification Through Deep Learning: AI-Driven Platforms for Enhanced Drug Discovery in Neurodegenerative Disease

Authors

  • Eric Verschueren Professor of Electrical Engineering, Ghent University

Keywords:

multi-target neuroprotection lead identification, deep learning, platforms, enhanced drug discovery, machine learning

Abstract

exhaustive knowledge of disease at the biochemical, genetic, and physiological levels, combined with clinical trials directly on patients, is not only important but absolutely essential for achieving efficacious therapies that truly improve patient outcomes. To date, the need for this comprehensive understanding cannot be overstated as it serves as the foundation for innovation in medical treatment.

Downloads

Published

30-06-2025

How to Cite

[1]
“Multi-Target Neuroprotection Lead Identification Through Deep Learning: AI-Driven Platforms for Enhanced Drug Discovery in Neurodegenerative Disease”, Cybersecurity & Net. Def. Research, vol. 5, no. 1, pp. 32–45, Jun. 2025, Accessed: Jun. 05, 2026. [Online]. Available: https://thesciencebrigade.com/cndr/article/view/879